A relação entre Síndrome Metabólica e risco cardiovascular em adultos obesos
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Resumo
Objetivo: Analisar a associação entre a síndrome metabólica e o risco cardiovascular em adultos, identificando os principais fatores envolvidos e suas implicações clínicas na prevenção e manejo das doenças cardiovasculares. Métodos: Trata-se de uma revisão integrativa da literatura realizada através das bases PubMED, Biblioteca Virtual em Saúde (BVS) e Periódico CAPES, usando os descritores: “Metabolic Syndrome”, “Cardiovascular Risk”, “Adults” e “Obesity” e obtendo o truncamento de pesquisa: (Metabolic Syndrome) AND (Cardiovascular Disease) AND (Cardiovascular Risk) AND (Adult) AND (Obesity). Foram encontrados 12.208 artigos, filtrados conforme critérios de inclusão (idiomas português, inglês e espanhol; período de 2020 a 2025; artigos completos) e exclusão (artigos duplicados, resumos, fora do escopo). Resultados: O perfil metabólico da obesidade, e não apenas o IMC, define o risco cardiovascular através da inflamação e resistência insulínica, exigindo avaliação abrangente e acompanhamento contínuo, pois o estado "metabolicamente saudável" pode ser transitório. Considerações finais: A avaliação do risco cardiovascular na obesidade deve ir além do IMC, priorizando a análise dos fenótipos metabólicos, inflamação e resistência insulínica.
##plugins.themes.bootstrap3.article.details##
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Referências
2. AROVAH NI, HEESCH KC. The association between cardiorespiratory fitness and metabolic syndrome diagnosis: A cross-sectional study in Indonesian middle-aged and older adults. Physical Activity Review, 2021; 9(2): 101–110.
3. BARUA L, et al. Prevalence of metabolic syndrome, its continuous severity score, and correlated cardiovascular risk among postmenopausal women of a selected rural area of Bangladesh. Bangabandhu Sheikh Mujib Medical University journal, 2023; 16(3): 133–138.
4. DAMIRI B, et al. Metabolic syndrome and related risk factors among adults in the northern West Bank, a cross-sectional study. International health, 2022; 14(4): 339–345.
5. DROZDZ D, et al. Obesity and cardiometabolic risk factors: From childhood to adulthood. Nutrients, 2021; 13(11): 4176.
6. KANG SY, et al. How obesity and metabolic syndrome affect cardiovascular events, progression to kidney failure and all-cause mortality in chronic kidney disease. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association, 2024; 39(5): 778–787.
7. LOPEZ-LOPEZ JP, et al. The prediction of Metabolic Syndrome alterations is improved by combining waist circumference and handgrip strength measurements compared to either alone. Cardiovascular diabetology, 2021; 20(1): 68.
8. LUO X, et al. Association between female androgen levels, metabolic syndrome, and cardiovascular disease: An NHANES analysis (2013-2016). International journal of women’s health, 2024; 16: 2087–2101.
9. MONTALVAN-SANCHEZ EE, et al. Prevalence of obesity and metabolic syndrome in the high cardiovascular risk setting of rural Western Honduras. Ethnicity & disease, 2023; 33(2): 124–129.
10. NAJEH H, et al. Epidemiological aspects of the association of the hypertriglyceridemic waist phenotype with metabolic syndrome and cardiovascular risk factors in Morocco. Case the Amazigh population from a geographic region called Souss. Roczniki Panstwowego Zakladu Higieny, 2024; 75(2): 185–193.
11. OĞUZ A, et al. Risk of cardiovascular events in patients with metabolic syndrome: Results of a population-based prospective cohort study (PURE Turkey). Anatolian journal of cardiology, 2020; 24(3): 192–200.
12. PARK MS, et al. Different impact of metabolic syndrome on the risk of incidence of the peripheral artery disease and the venous thromboembolism: A nationwide longitudinal cohort study in South Korea. Reviews in cardiovascular medicine, 2023; 24(4): 113.
13. PETERSEN MC, et al. Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity. Cell metabolism, 2024; 36(4): 745- 761.
14. ROJO M, et al. Relationship of mitochondrial DNA oxidation and content with metabolic syndrome and cardiovascular risk in obesity phenotypes. Journal of obesity, 2024; 1: 3008093.
15. ROMERO-ROJAS V, et al. Factores del síndrome metabólico en el riesgo cardiovascular en pobladores peruanos. Rev Cubana Invest Bioméd, 2023; (42): 2918.
16. RUS M, et al. Prevalence and risk factors of metabolic syndrome: A prospective study on cardiovascular health. Medicina (Kaunas, Lithuania), 2023; 59(10): 1711.
17. SCHRODER JD, et al. Effects of time-restricted feeding in weight loss, metabolic syndrome and cardiovascular risk in obese women. Journal of translational medicine, 20221; 19(1): 3.
18. SEO DH, et al. Association between metabolically healthy obesity and subclinical atherosclerosis in the cardiovascular and metabolic diseases etiology research center (CMERC) cohort. Journal of clinical medicine, 2022; 11(9): 2440.
19. SEZGIN Y, et al. Evaluation of the relationship between body composition measurements and metabolic syndrome severity score in obese individuals. Medicine, 2025; 104(12): 41943.
20. SZCZUDLIK E, et al. The age of the obesity onset is a very important factor for the development of metabolic complications and cardiovascular risk in children and adolescents with severe obesity. European journal of pediatrics, 2024; 183(9): 3833–3841.
21. TABARA Y, et al. Association between metabolic syndrome and cardiovascular events in a Japanese population with and without obesity: The Shizuoka kokuho database study. Journal of atherosclerosis and thrombosis, 2025; 65357.
22. VAN EDE ES, et al. The impact of duration and severity of obesity exposure on cardiometabolic health. Obesity surgery, 2024; 34(7): 2587–2595.
23. XIONG Q, et al. Comparison of cardiovascular disease risk association with metabolic unhealthy obesity identified by body fat percentage and body mass index: Results from the 1999-2020 National Health and Nutrition Examination Survey. PloS one, 2024; 19(8): 305592.
24. YAZDANPANAH MH, et al. The association of metabolic syndrome and its components with electrocardiogram parameters and abnormalities among an Iranian rural population: The fasa PERSIAN cohort study. Diabetes, metabolic syndrome and obesity: targets and therapy, 2020; 13: 2975–2987.
25. ZHAO K e LING S. Gender-specific association between a novel atherogenic index of plasma, metabolic parameters and inflammation among obese adults. BMC endocrine disorders, 2025; 25(1): 38.
26. ZHOU Y, et al. Associations between metabolic overweight/obesity phenotypes and mortality risk among patients with chronic heart failure. Frontiers in endocrinology, 2024; 15: 1445395.